Carleton B. Simpson - 27 Jan 2026 Form 4 Insider Report for UNITIL CORP (UTL)

Signature
/s/ Kumiko A. Shortill, attorney-in-fact for Carleton B. Simpson
Issuer symbol
UTL
Transactions as of
27 Jan 2026
Net transactions value
$0
Form type
4
Filing time
29 Jan 2026, 16:55:43 UTC
Previous filing
05 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Simpson Carleton B SVP, Gen. Counsel & Secretary 6 LIBERTY LANE WEST, HAMPTON /s/ Kumiko A. Shortill, attorney-in-fact for Carleton B. Simpson 29 Jan 2026 0002091692

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTL Common stock, no par value Award $0 +1,590 $0.000000 0 27 Jan 2026 Direct F1
transaction UTL Common stock, no par value Award $0 +1,590 +45% $0.000000 5,100 27 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTL Contingent grant of common stock Award +795 +166% 1,275 27 Jan 2026 Common stock 795 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest 25% per year over four years from date of grant. Shares will be valued at current market price on date of vesting.
F2 Shares were granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Shares generally will vest after three-year performance period based on the attainment of certain performance thresholds of certain performance goals. Shares will be valued at current market price on date of vesting.
F3 Shares may be granted pursuant to the Unitil Corporation Third Amended and Restated 2003 Stock Plan. Any such shares would be granted after a three-year performance period ending on December 31, 2028, based on the attainment of certain performance thresholds of certain performance goals. Any such shares would be valued at current market price on date of grant.